Do vincristine, methotrexate, or ondansetron cause vasodilation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vincristine and Ondansetron Do Not Cause Vasodilation; Methotrexate Has No Direct Vasodilatory Effects

None of these three medications—vincristine, methotrexate, or ondansetron—cause vasodilation. In fact, vincristine can cause hypertension and hypotension through autonomic dysfunction, not vasodilation.

Vincristine: Causes Hypertension and Hypotension (Not Vasodilation)

Vincristine's cardiovascular effects are the opposite of vasodilation:

  • The FDA label explicitly states that vincristine causes both hypertension AND hypotension 1
  • These blood pressure changes result from autonomic nervous system dysfunction (neurotoxicity), not from direct vascular effects
  • One case report documented severe orthostatic hypotension during vincristine therapy that resolved when the drug was discontinued 2—this was due to autonomic neuropathy affecting blood pressure regulation, not vasodilation
  • The guideline literature confirms vincristine's neurotoxic profile but makes no mention of vasodilatory properties 3, 4, 5, 6, 7

Clinical pitfall: The hypotension seen with vincristine is NOT from vasodilation—it's from autonomic nerve damage affecting the body's ability to regulate blood pressure normally. This is a critical distinction because the management differs entirely.

Methotrexate: No Vasodilatory Effects

Methotrexate has an extensive adverse effect profile, but vasodilation is not among them:

  • The FDA label lists cardiovascular effects as pericarditis, pericardial effusion, hypotension, and thromboembolic events—but NOT vasodilation 8
  • The hypotension mentioned occurs through different mechanisms (likely related to systemic toxicity or fluid shifts), not direct vasodilation
  • Multiple guidelines using methotrexate in ALL, Crohn's disease, and other conditions make no reference to vasodilatory effects 4, 5, 6, 9, 7, 10

Ondansetron: No Vasodilatory Properties

Ondansetron is a 5-HT3 receptor antagonist used for nausea/vomiting:

  • There is no evidence in the provided literature that ondansetron causes vasodilation
  • One recent guideline mentions ondansetron in the context of amniotic fluid embolism treatment, but specifically notes that "serotonin antagonism with ondansetron manifests limited hemodynamic consequence" 11
  • Ondansetron is successfully used to prevent methotrexate-induced nausea without reports of vasodilatory effects 12

What Actually Causes Vasodilation in Oncology Settings

If you're concerned about vasodilation in patients receiving these chemotherapy agents, consider:

  • Corticosteroids (often given with these regimens) can affect vascular reactivity, though they typically enhance vasoconstriction rather than cause vasodilation 13
  • Sepsis or cytokine release syndrome from the underlying disease or treatment
  • Other supportive medications in the treatment regimen

Bottom line: None of these three drugs cause vasodilation. Vincristine causes blood pressure instability through neurotoxicity, while methotrexate and ondansetron have no direct vasodilatory effects.

References

Guideline

nccn guidelines insights: acute lymphoblastic leukemia, version 1.2017.

Journal of the National Comprehensive Cancer Network : JNCCN, 2017

Guideline

acute lymphoblastic leukemia, version 2.2024, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2024

Research

Glucocorticoids and vascular reactivity.

Current vascular pharmacology, 2004

Related Questions

How do glucocorticoids (corticosteroids) potentiate the effects of vasopressor medications?
What are the recommended antiemetic medications and administration schedules for methotrexate-induced nausea?
What is the recommended timing for administering ondansetron (generic name) for methotrexate-related nausea?
What are the best antiemetics for a Crohn's disease (Crohn's) flare?
What are the symptoms and recommended treatments for cluster headaches?
What is the most appropriate next clinical trial for a man with metastatic castration‑resistant prostate cancer who has progressed after standard androgen‑receptor signaling inhibitor therapy (and, if applicable, taxane chemotherapy)?
In a patient taking oral terbinafine 250 mg daily for onychomycosis who is also on a statin, does terbinafine affect cholesterol levels or require special monitoring?
When should Flublok (recombinant hemagglutinin influenza vaccine) be used instead of a standard quadrivalent inactivated influenza vaccine?
In a 33‑year‑old woman with depression treated with sertraline 150 mg who is experiencing restlessness and anxiety after a new diagnosis of Attention‑Deficit/Hyperactivity Disorder and is taking quetiapine (Seroquel) 25 mg for sleep, how should her medication regimen be managed?
Should a brain MRI be performed in a 3‑month‑old female infant treated for presumed meningitis after an unsuccessful lumbar puncture, now clinically improved with negative blood and urine cultures, to rule out hydrocephalus or other intracranial pathology?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.